Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Does the Metal-Fatigue Principle Apply to Elderly Bones?

Mary Beth Nierengarten  |  Issue: August 2018  |  August 16, 2018

He and his colleagues are always looking for new information on bone fractures in older patients. One area of research from the study he thinks reasonable to pursue is to potentially target cells involved in bone repair and quality. “It may be important to look at different cells to target therapeutically,” he says. “Current medications primarily look at minimizing the rate of turnover of cells as opposed to looking at the cells that actually do the repair.”

Look to the Future

Emphasizing the prospective nature of the study, Dr. Acevedo says more research is needed to better understand the role of osteocytes to repair damaged bone. Also needed are better ways to identify which patients may be at fracture risk because of microcracks. Although imaging is useful, she says it is not sufficient to detect very small cracks. The only common symptom currently indicative of a patient with microcracks is pain.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

She says pain in an elderly patient may be a sign of someone at risk of fracture. “This study tries to make clinicians aware that stress fracture can occur in the elderly under daily activities,” she says.

For Dr. Vail the research points to new avenues for prevention and treatment of skeletal pathologies that lead to fracture. Citing the great advances that have revolutionized the treatment of inflammatory arthritis with the use of tumor necrosis factor (TNF) inhibitors, he says he is “hopeful that these processes of identifying and understanding microtrauma of aging would provide avenues for similar breakthroughs of medical treatment of skeletal pathologies.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

Reference

  1. Acevedo C, Stadelmann VA, Pioletti DP, et al. Fatigue as the missing link between bone fragility and fracture. Nat Biomed Eng. 2018;2(2):62–71.

Page: 1 2 3 | Single Page
Share: 

Filed under:Conditions Tagged with:bonebone breakbone remodelingFractures

Related Articles

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

    Reading Rheum

    March 1, 2007

    Handpicked Reviews of Contemporary Literature

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences